PepMix™ HSV1 (gD) is an HSV-1 glycoprotein D peptide pool for antigen-specific T-cell stimulation. Its 96 overlapping peptides span the gD sequence of strain KOS (UniProt A1Z0Q5), using 15-mers with an 11-amino-acid overlap. The pool supports cellular immune-response studies directed at this defined HSV-1 envelope antigen
Pool of 96 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope protein (Swiss-Prot ID: A1Z0Q5) of Herpes Simplex Virus - HHV-1 (strain KOS).
PepMix™ HSV1 (gD) - Specifications
- Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
- Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) - (equivalent to an average purity of 85%)
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer, Encephalitis, Genital herpes, Oral Herpes, Infection
- Standard Delivery Time: 2-5 days
Applications
- Assessment of HSV-1 gD-reactive T-cell responses by ELISpot
- Intracellular cytokine staining (ICS) following gD peptide stimulation
- Immune monitoring of responses to HSV-1 glycoprotein D
Are you interested in your own custom PepMix? Choose your sequence, amount, purity and pool format. We will assist you along the way. Custom PepMix Peptide Pools.
HSV-1 gD Peptides for Infectious Disease Research
Within JPT’s PepMix™ Peptide Pools for Infectious Disease Antigens, this PepMix focuses on glycoprotein D from HSV-1 strain KOS. It provides a defined antigen stimulus for herpes simplex T-cell studies in which the viral type and source strain need to be documented. The HSV-1 identity distinguishes this pool from the separately available HSV-2 gD product.
Overlapping Coverage of HSV-1 Glycoprotein D
The 96-peptide scan brings multiple regions of KOS gD into one pooled reagent, avoiding the need to select a single epitope before initial T-cell screening. Each peptide is supplied at Development Grade purity above 70% by HPLC/MS, with a defined amount per peptide for assay preparation.
Need individual HSV-1 sequences for follow-up studies?
Explore JPT Custom Peptide Synthesis for project-specific peptide requirements after pooled antigen screening.